| The N-terminal domain of EBNA1 acts as a suppressor of the HER2/neu oncogene. | None |
| This study confirms that Ets-1 is a downstream effector of oncogenic HER2, associated with MMP-1. | None |
| Transgenic oncogene mice. Tumor phenotype predicts genotype. | None |
| Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater. | None |
| These results suggest an oncogenic role for HER2/neu in anti-BPDE-induced carcinogenesis. | None |
| LED-FISH: Fluorescence microscopy based on light emitting diodes for the molecular analysis of Her-2/neu oncogene amplification. | None |
| tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO). | None |
| Frequent induction of mammary carcinomas following neu oncogene transfer into in situ mammary epithelial cells of susceptible and resistant rat strains. | None |
| c-erbB-2 proto-oncogene product. | None |
| Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. | None |
| [Proto-oncogene C-erbB-2 and human cancer]. | None |
| Polymorphic changes of cell phenotype caused by elevated expression of an exogenous NEU proto-oncogene. | None |
| Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. | None |
| Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active. | None |
| [Expression of EGF receptor and c-neu oncogene product in chordomas]. | None |
| NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. | None |
| Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. | None |
| HER-2/neu (657-665) represents an immunogenic epitope of HER-2/neu oncoprotein with potent antitumor properties. | None |
| Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies. | None |
| Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. | None |